Literature DB >> 3063114

Structural manifestations of diabetic cardiomyopathy in the rat and its reversal by insulin treatment.

E W Thompson1.   

Abstract

The structural effects of diabetes and subsequent insulin treatment upon the contractile and supporting elements of the rat myocardium were examined at progressive stages of both untreated and treated disease. Diabetes was induced by intravenous injection of alloxan, and tissue was examined after 6, 12, and 26 weeks. Insulin treatment began after 12 weeks of diabetes and tissue from these animals was examined after the same intervals. Within the cardiocytes, diabetes produced a focal yet progressive loss of myofibrils, transverse tubules, and sarcoplasmic reticulum, and separation of the fasciae adherens was evident at the intercalated disk. Mitochondrial damage was not evident. These cytoplasmic alterations were accompanied by intercellular and perivascular deposition of connective tissue, thickening of the endothelial cytoplasm with pinocytotic hyperactivity, and characteristic basal laminar changes. When insulin treatment began after 12 weeks of diabetes, most, but not all, of these changes were reversed, and this reversal was essentially complete within 6-12 weeks. Even with longer periods of insulin treatment, cardiocytes still exhibited scattered areas of myofibril loss and extracellular matrix was retained. In contrast, diabetic changes in the intercalated disk and capillaries, including their basal laminae, were completely and rapidly reversed. It is hypothesized that the structural manifestations of diabetic cardiomyopathy consist of two major components; the first is a short-term, physiologic adaptation to metabolic alterations, while the other represents degenerative changes for which the myocardium has only a limited capacity for repair.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063114     DOI: 10.1002/aja.1001820308

Source DB:  PubMed          Journal:  Am J Anat        ISSN: 0002-9106


  17 in total

1.  Astragalus prevents diabetic rats from developing cardiomyopathy by downregulating angiotensin II type2 receptors' expression.

Authors:  Changyun Li; Linsheng Cao; Qiutang Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

2.  Elevated levels of nonesterified fatty acids in the myocardium of alloxan diabetic rats.

Authors:  J Chattopadhyay; E W Thompson; H H Schmid
Journal:  Lipids       Date:  1990-06       Impact factor: 1.880

3.  Effects of the start time of glycemic control on erectile function in streptozotocin-induced diabetic rats.

Authors:  O Kwon; S Y Cho; J-S Paick; S W Kim
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

4.  Nonesterified fatty acids in normal and diabetic rat sciatic nerve.

Authors:  J Chattopadhyay; E W Thompson; H H Schmid
Journal:  Lipids       Date:  1992-07       Impact factor: 1.880

5.  Calcium-supported calpain degradation rates for cardiac myofibrils in diabetes. Sulfhydryl and hydrophobic interactions.

Authors:  A N Belcastro; J S Gilchrist; J A Scrubb; G Arthur
Journal:  Mol Cell Biochem       Date:  1994-06-15       Impact factor: 3.396

6.  Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice.

Authors:  T M Camp; S C Tyagi; R M Senior; M R Hayden; S C Tyagi
Journal:  Diabetologia       Date:  2003-08-20       Impact factor: 10.122

Review 7.  Structural changes in the myocardium during diabetes-induced cardiomyopathy.

Authors:  Ernest Adeghate; Jaipaul Singh
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 8.  The diabetic myocardium.

Authors:  Thomas H Marwick
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

9.  Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats.

Authors:  A Warley; J M Powell; J N Skepper
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

Review 10.  Diabetic cardiomyopathy.

Authors:  Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.